Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 36INDUSTRY 6OTHER_GOV 2NETWORK 1FED 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Imiquimod 2Docetaxel 2Celecoxib 22-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 2pembrolizumab 1pasireotide 1gadolinium ethoxybenzyl DTPA 1enzalutamide 1Uterine Myomectomy 1Topotecan 1Tablets 1Sildenafil Citrate 1Reference Standards 1Pentoxifylline 1Mindfulness 1Mass Screening 1Ketoconazole 1Itraconazole 1Hysterectomy 1Hypnosis 1Herpes Zoster Vaccine 1Fecal Microbiota Transplantation 1Exercise 1Estramustine 1Epirubicin 1Doxycycline 1Cryotherapy 1Biopsy, Large-Core Needle 1Azacitidine 1Androgen Antagonists 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × FED × Azacitidine × Clear all
NCT00728520 2008-08-06

Trial With Azacitidine in Newly Diagnosed Acute Myelogenous Leukemia (AML) Veterans Administration (VA) Elderly Patients Not Eligible for Standard Induction Therapy

Kansas City Veteran Affairs Medical Center

Phase 2 Unknown
40 enrolled
Other hematologic neoplasm

Leukemia, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡